beta-D-Galp-(1->3)-D-GlcpN → D-Galactosamine

HRID 1585189

Reaktionsgleichung

Reaktionsgleichung von HRID 1585189
[O:1]([C@H:13]1[C@H:19]([OH:20])[C@@H:18]([CH2:21][OH:22])[O:17][CH:15]([OH:16])[C@@H:14]1[NH2:23])[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O.[O:24]([C@H:36]1[C@@H:42]([OH:43])[C@@H:41]([CH2:44][OH:45])[O:40][CH:38]([OH:39])[C@@H:37]1[NH2:46])[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O>>[OH:16][CH:15]1[O:17][C@H:18]([CH2:21][OH:22])[C@@H:19]([OH:20])[C@H:13]([OH:1])[C@H:14]1[NH2:23].[OH:39][CH:38]1[O:40][C@H:41]([CH2:44][OH:45])[C@H:42]([OH:43])[C@H:36]([OH:24])[C@H:37]1[NH2:46]

Komponenten

4

Edukt 2

HCID 91861991beta-D-Galp-(1->3)-D-GlcpNHCID 91862027GlyTouCan:G14446DQ

Produkt 2

HCID 24154D-GalactosamineHCID 439213D-Glucosamine

Versuchsvorschrift

Synthesis of Galβ1-3GlcNH2 βSEt and Galβ1-3GalNH2 βSEt. See example 1, similar conditions and enzyme may be used, but instead GlcNH2 βSEt, or GalNH2 βSEt to obtain the latter product, is used as the acceptor. Here, extraction is less favorable for isolation, and instead ion-exchanger as above may be used followed by e.g. precipitation or a second chromatographic step.

Quellen und Nachweise

ORD-Eintrag
ord-a5ab09a504e049068eafe2b223197765
Quelldatensatz
uspto-grants-1999_08
Patentnummer
US05936075

Verknüpfte Notizen

Wird geladen…